Pharmaceutical manufacturing · Tashkent, Uzbekistan
Global Standards.Local Strength.Better Healthcare.
Grandene is building the next generation of pharmaceutical manufacturing in Uzbekistan — combining modern infrastructure, robust quality systems, international expertise and a commitment to making high-quality medicines more accessible.
753,000sq ft
Manufacturing site
8
Production lines
7
Dosage forms
400+
Employees
3.77bn
Units per year
Who we are
Building Pharmaceutical Excellence in Uzbekistan
Grandene is a pharmaceutical manufacturing company developed with a long-term vision: to strengthen local manufacturing capabilities, enable technology transfer, support import substitution and create a platform for regional and international pharmaceutical growth.
Our approach brings together advanced manufacturing, disciplined quality systems, skilled people and international collaboration. From product localization to future export opportunities, we are building capabilities designed to support the evolving needs of healthcare.
Tashkent Pharma Park
753,000sq ft
Manufacturing site
- 8 Production lines
- 7 Dosage forms
- 3.77 bn Units per year
- 400+ Employees
Production capacity
Built for scale: billions of doses a year
Grandene's annual production capacity by dosage form, across eight production lines at Tashkent Pharma Park.
Total annual capacity
3.77
billion units per year
Annual design capacity by dosage form.
Our focus
Six priorities shaping Grandene
Quality systems aligned with internationally recognized expectations
Technology transfer and localization
Partnership-driven product development and manufacturing
Development of skilled pharmaceutical talent
Responsible and sustainable operations
Manufacturing
Manufacturing for Today. Building for Tomorrow.
Grandene is being developed as a multi-capability pharmaceutical platform at Tashkent Pharma Park. Our manufacturing strategy is centered on reliable processes, controlled environments, appropriate automation, robust documentation and continuous improvement.
Seven dosage forms. One quality standard.
Tablets
Oral solid dosage tablets produced through controlled, reproducible processes.
3.165 bn units / year
Capsules
Hard capsules designed for accurate, consistent oral dosing.
369 mn units / year
Sachets
Powders and granules in single-dose sachets for convenient administration.
18 mn units / year
Effervescent tablets
Moisture-sensitive effervescent tablets requiring tightly controlled environments.
Softgel capsules
Soft capsules for liquid and semi-solid formulations.
180 mn units / year
Ointments & creams
Semi-solid topical preparations for dermatological use.
9 mn units / year
Suppositories
Suppositories manufactured with precise moulding and temperature control.
30 mn units / year
8
Production lines
Learn moreTechnology
International technology, local expertise
Our production floor and laboratories bring together equipment and instrumentation from leading manufacturing nations — operated by a growing team of Uzbek pharmaceutical professionals.
Manufacturing equipment
Production machinery from established equipment manufacturers in three countries.
- India
- China
- South Korea
Laboratory instruments
Analytical and laboratory instrumentation from five leading manufacturing nations.
- USA
- Germany
- Japan
- United Kingdom
- India
GMP & regulatory framework
Built toward recognised GMP standards
Grandene's facility, quality systems and documentation are being developed in line with the following GMP frameworks. Certification status is communicated only after formal approval by the relevant authority.
EU-GMP
European Union Good Manufacturing Practice
EAEU GMP
Eurasian Economic Union GMP requirements
Uzbek GMP
Good Manufacturing Practice of the Republic of Uzbekistan
Partnerships
International Collaboration
We believe strong pharmaceutical manufacturing is built through collaboration. Grandene welcomes engagement with pharmaceutical companies, technology owners, formulation partners, equipment specialists and quality experts for technology transfer, localization and long-term manufacturing partnerships.
- Pharmaceutical companies
- Technology owners
- Formulation partners
- Equipment specialists
- Quality experts
Grandene
Export horizons
From Tashkent to wider markets
Grandene is being built with export in mind. Our target markets include Europe and the countries of the Eurasian region, subject to product registration in each market.
- Europe
- Russia
- Kazakhstan
- Belarus
- Armenia
- Kyrgyzstan
From Uzbekistan to wider markets
Creating pharmaceutical capability with purpose, precision and partnership.